|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.75 AUD | -3.37% |
|
-1.01% | -3.92% |
| Apr. 24 | Germany's Evotec Appoints Permanent CEO | MT |
| Apr. 18 | Evotec, Variant Bio Team Up to Develop Treatment for Fibrosis | MT |
EVT Limited reported earnings results for the full year ended June 30, 2023. For the full year, the company reported net income was AUD 106.53 million compared to AUD 53.32 million a year ago. Basic earnings per share from continuing operations was AUD 0.661 compared to AUD 0.331 a year ago.
Diluted earnings per share from continuing operations was AUD 0.655 compared to AUD 0.329 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -3.92% | 1.24B | |
| +17.97% | 4.62B | |
| +25.27% | 2.16B | |
| -.--% | 1.88B | |
| -15.44% | 1.65B | |
| -10.07% | 1.4B | |
| -10.51% | 1.14B | |
| -20.74% | 1.1B | |
| -44.28% | 942M | |
| -.--% | 818M |
EVT LIMITED 
